Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ENHO | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | CTB-50L17.10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | KCTD19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | SYT7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ARFGAP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | DUS2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | RPN2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | NCOA5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | OST4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | DPP10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |